# OnCo record flaura (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/flaura/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "flaura", "NCT02296125" ;
  schema:name "FLAURA"@en ;
  schema:description "FLAURA showed that starting with the third-generation EGFR drug osimertinib, rather than saving it for later, kept lung cancer under control for almost twice as long and helped people live longer."@en ;
  schema:url <https://onco.cc/trials/flaura/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02296125>, <https://doi.org/10.1056/NEJMoa1713137>, <https://doi.org/10.1056/NEJMoa1913662> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/osimertinib/>, <https://onco.cc/drugs/gefitinib/>, <https://onco.cc/drugs/erlotinib/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:terms <https://onco.cc/terms/egfr-exon19-l858r/>, <https://onco.cc/terms/tki-term/> ;
  onco:people <https://onco.cc/people/jean-charles-soria/>, <https://onco.cc/people/suresh-ramalingam/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-flaura-nejm-2018/> .